Coastal Infusion Administers Ilaris®

Ilaris (canakinumab) is used to treat certain types of arthritis, such as Still’s Disease (SJIA). It is also used to treat rare periodic fever syndromes including Cryopyrin-Associated Periodic Syndromes (CAPS), inflammation and swelling of joints and other body parts; and Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS), which is characterized by recurrent fever episodes, abdominal pain, skin rash, and inflammation affecting various organs and tissues in the body.

The active substance in Ilaris, canakinumab, is a monoclonal antibody that has been designed to recognize and attach to a messenger molecule called interleukin-1 beta. This messenger causes inflammation and is found in elevated levels in patients with periodic fever syndromes, Still’s Disease, and gouty arthritis. By attaching to interleukin-1 beta, canakinumab blocks its activity, helping to reduce inflammation thereby relieving the symptoms of the diseases.

What It Treats

• Cryopyrin-Associated Periodic Syndromes (CAPS)
• Systemic Juvenile Idiopathic Arthritis (SJIA)
• Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)

Prescribed By

Ilaris is most often prescribed by Immunologists and Rheumatologists.

How it’s Administered

Ilaris is administered by subcutaneous injection. Ilaris injections take only a few minutes.

Frequency

Ilaris is generally administered every four or eight weeks.

Additional Resources

• Ilaris Website
• Prescribing Information
• Co-Pay Assistance

The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies